|
TMEM192 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.09860009978036E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.30250002292354E-09 |
| Normal-vs-Stage2 |
7.601400E-04 |
| Normal-vs-Stage3 |
2.56010002086526E-09 |
| Normal-vs-Stage4 |
1.40410000293301E-08 |
| Stage1-vs-Stage2 |
2.571400E-01 |
| Stage1-vs-Stage3 |
3.553800E-01 |
| Stage1-vs-Stage4 |
1.963390E-01 |
| Stage2-vs-Stage3 |
9.182000E-02 |
| Stage2-vs-Stage4 |
4.840100E-02 |
| Stage3-vs-Stage4 |
5.644400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.61914967281518E-12 |
| Normal-vs-AfricanAmerican |
2.099000E-03 |
| Normal-vs-Asian |
2.08010000002368E-06 |
| Caucasian-vs-AfricanAmerican |
2.868400E-01 |
| Caucasian-vs-Asian |
7.594800E-01 |
| AfricanAmerican-vs-Asian |
4.676000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.8497998646252E-10 |
| Normal-vs-Female |
1.42279998893713E-09 |
| Male-vs-Female |
2.539400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.55059999471663E-08 |
| Normal-vs-Age(41-60Yrs) |
2.13740025678533E-10 |
| Normal-vs-Age(61-80Yrs) |
4.78230000044988E-08 |
| Normal-vs-Age(81-100Yrs) |
6.184800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.776400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.390600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.396600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.694200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.740600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.158800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.247600E-02 |
| Classical-VS-Follicular |
3.123400E-01 |
| Classical-VS-Other |
2.403800E-01 |
| Classical-VS-Normal |
3.20379944795945E-10 |
| Tall-VS-Follicular |
3.512100E-02 |
| Tall-VS-Other |
6.176800E-01 |
| Tall-VS-Normal |
3.27379999776056E-08 |
| Follicular-VS-Other |
2.256800E-01 |
| Follicular-VS-Normal |
1.995380E-04 |
| Other-VS-Normal |
2.079100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.20209999918831E-09 |
| Normal-vs-N1 |
6.76019999978905E-08 |
| N0-vs-N1 |
7.621900E-02 |
|
|
